GSK - Rasio utang marang kapitalisasi buku gsk.com

GSK plc (GSK) relies on years of trust from physicians worldwide. The ratio of the company's financial debt to balance sheet equity clearly demonstrates the financial stability of this behemoth, which dominates the vaccines and HIV therapy segments. Stable demand allows for margin expansion despite R&D expenditures. The value of 0.99 shows the current value of the debt load metric.

GSK Corp - Utang-utang marang kapitalisasi buku GSK (periode 04.07.2022 - 27.10.2026)

gsk.com (GSK) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Bagan rega GlaxoSmithKline|GSK - Konsensus nilai wajar

- data kapitalisasi pasar:

Nilai pasar GSK Corp|GSK - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham GSK|GSK - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih gsk.com|GSK - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal GSK plc|GSK - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas GlaxoSmithKline|GSK - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku GSK Corp

Ringkesan analitik perusahaan:GSK (GSK Corp)

For GSK plc (GSK), which owns a distributed network of sterile plants across the US and Europe, the balance of borrowed funds is critical for maintaining operational production stability. By analyzing the company's total debt relative to its book capitalization, an investor assesses the volatility of the credit load against equity, allowing for a precise determination of the risks of overpaying for asset hedging during periods of market volatility.

Pesaing GSK plc